Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Benkert

Showing results (141-150 of 171) with videos related to

Pageof 18
Sort By:
Journal of Clinical Psychopharmacology|April 29, 1998
Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndromeF Müller-Siecheneder, M J Müller, A Hillert, et al.
Lancet (London, England)|January 7, 1984
Corticotropin-releasing-factor induced pituitary-adrenal response in depressionF Holsboer, A Gerken, A Steiger, et al.
Psychiatric Developments|January 1, 1989
Avoidance behaviour and major depression in panic disorder: a report from the Cross-National Collaborative Panic StudyW Maier, R Rosenberg, N Argyle, et al.
Psychopharmacology|July 1, 1997
Analysis of sleep EEG microstructure in subchronic paroxetine treatment of healthy subjectsJ Röschke, P Kögel, R Schlösser, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1995
Effects of corticotropin-releasing hormone on respiratory parameters during sleep in normal menK Mann, J Röschke, O Benkert, et al.
The British Journal of Psychiatry : the Journal of Mental Science|August 17, 1999
Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobiaB Loerch, M Graf-Morgenstern, M Hautzinger, et al.
Archives of General Psychiatry|November 1, 1993
Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family studyW Maier, D Lichtermann, J Minges, et al.
Neuropsychobiology|September 11, 2002
Long-term effects of the substituted benzamide derivative amisulpride on baseline and stimulated prolactin levelsR Schlösser, G Gründer, I Anghelescu, et al.
Pharmacopsychiatry|May 1, 1997
A double-blind study comparing paroxetine and maprotiline in depressed outpatientsA Szegedi, H Wetzel, D Angersbach, et al.
Psychiatry Research|March 9, 2000
Antipsychotic effects and tolerability of the sigma ligand EMD 57445 (panamesine) and its metabolites in acute schizophrenia: an open clinical trialM J Müller, G Gründer, H Wetzel, et al.
Pageof 18

Showing results (141-150 of 171) with videos related to

Sort By:
Pageof 18
Journal of Clinical Psychopharmacology|April 29, 1998
Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndromeF Müller-Siecheneder, M J Müller, A Hillert, et al.
Lancet (London, England)|January 7, 1984
Corticotropin-releasing-factor induced pituitary-adrenal response in depressionF Holsboer, A Gerken, A Steiger, et al.
Psychiatric Developments|January 1, 1989
Avoidance behaviour and major depression in panic disorder: a report from the Cross-National Collaborative Panic StudyW Maier, R Rosenberg, N Argyle, et al.
Psychopharmacology|July 1, 1997
Analysis of sleep EEG microstructure in subchronic paroxetine treatment of healthy subjectsJ Röschke, P Kögel, R Schlösser, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1995
Effects of corticotropin-releasing hormone on respiratory parameters during sleep in normal menK Mann, J Röschke, O Benkert, et al.
The British Journal of Psychiatry : the Journal of Mental Science|August 17, 1999
Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobiaB Loerch, M Graf-Morgenstern, M Hautzinger, et al.
Archives of General Psychiatry|November 1, 1993
Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family studyW Maier, D Lichtermann, J Minges, et al.
Neuropsychobiology|September 11, 2002
Long-term effects of the substituted benzamide derivative amisulpride on baseline and stimulated prolactin levelsR Schlösser, G Gründer, I Anghelescu, et al.
Pharmacopsychiatry|May 1, 1997
A double-blind study comparing paroxetine and maprotiline in depressed outpatientsA Szegedi, H Wetzel, D Angersbach, et al.
Psychiatry Research|March 9, 2000
Antipsychotic effects and tolerability of the sigma ligand EMD 57445 (panamesine) and its metabolites in acute schizophrenia: an open clinical trialM J Müller, G Gründer, H Wetzel, et al.
Pageof 18